Drug intelligence / Profile preview

1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C26H28N4O3 and a molecular weight of approximately 444.5 g/mol[6][1]. It is listed in chemical and pharmaceutical databases such as PubChem (CID 25155578), DrugBank (DB08738), and ChEMBL (CHEMBL459149)[6][1]. The structure features a quinoxalinone core substituted with phenyl and pyrrolidine-containing side chains. According to available data, it belongs to the class of alpha amino acid amides[6]. There is no evidence that this compound has been approved for clinical use; it appears to be an experimental or research molecule. No specific mechanism of action, biological target, or therapeutic indication has been established in public sources.

Other names
1-(3-oxo-3-((2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl)propyl)-3-phenylquinoxalin-2(1H)-one1-(3-oxo-3-((2S)-2-(pyrrolidine-1-carbonyl)pyrrolidin‑1‑yl)propyl)-3‑phenyl‑1,2-dihydroquinoxalin‑2-oneCHEMBL459149CHEMBL-459149CHEMBL 459149

Beyond the preview

Go deeper on 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call